LikeFolio Weekly Roundup

Core inflation rose 0.2% in May, bringing the year-over-year rate to 2.7%. That’s above expectations and higher than April’s 2.6%, signaling that price pressure hasn’t fully eased. Headline inflation held at 2.3%, but the more telling data came from consumers. Spending fell when it was expected to rise, and personal income dropped 0.4%, the biggest monthly decline since 2022. Demand is cooling at the same time services costs are still climbing a bit. That’s not quite the clean setup investors had hoped for heading into the second half.

Stocks moved higher anyway. 

The S&P 500 traded at record highs today as investors look past the inflation miss and focus on broader relief: tariffs are paused, Powell didn’t push back this week, and economic growth is slowing just enough to keep rate cuts on the table. 

President Trump confirmed a signed agreement with China that reopens rare earth mineral exports to the U.S., addressing a key supply-chain risk for tech and defense sectors. The deal helped lift sentiment across industrials and semiconductors, adding another tailwind heading into Q3.

Here’s an overview of the biggest news and largest movers in our portfolio through close on Thursday, June 26:

Infinite Hold Update

Tesla (TSLA): Tesla’s robotaxi service officially began June 22 in Austin with a limited fleet of 10–20 Model Y vehicles operating within geofenced zones, offering rides at a promotional flat rate of $4.20. Each ride includes a human safety monitor in the front passenger seat to assure on‑road oversight.

Despite critical commentary, investor sentiment remains bullish, with TSLA stock rising approximately +8% on launch day and maintaining a net gain for the week. 

We are taking the upside on the next bit TSLA binary bet – Andy and Landon broke this down in detail on this week’s Founders Call. Watch below:

Bitcoin: Bitcoin fell to $98,286 over the weekend after the U.S. conducted airstrikes on Iranian nuclear facilities, triggering a wave of geopolitical uncertainty. The selloff was short-lived, with Bitcoin rebounding to trade near $107K by midweek. 

On Tuesday, the FHFA instructed Fannie Mae and Freddie Mac to begin drafting rules that would allow regulated crypto holdings to count toward mortgage eligibility. This marks the first time Bitcoin is being considered in the U.S. housing finance system. It opens the door for crypto to be recognized as real collateral in one of the largest credit markets in the world.

Amazon (AMZN): Amazon shares rallied this week as the market priced in a string of strategic expansions across its core businesses this week.

Amazon announced that by the end of 2025 it will extend same-day and next-day Prime delivery to over 4,000 small cities and rural communities, backed by a $4 billion investment in new distribution hubs and AI-driven inventory management.

Amazon also pledged up to £54 billion to expand its U.K. operations over the next three years. The investment covers new robotics-powered fulfillment centers, additional AWS data centers, and film production infrastructure. CEO Andy Jassy emphasized that AI-driven efficiencies will allow Amazon to grow output while relying on fewer workers.  

Portfolio Update

Robinhood (HOOD): All-Time High

Robinhood hit all-time highs this week after launching a crypto deposit match that rewards incoming transfers with up to 2% once community inflows cross $500 million. This campaign is timed nicely to increase assets under custody ahead of Ethereum ETF trading starting July 2, which could drive a spike in retail crypto activity. More assets on-platform mean higher potential for trading revenue, interest income, and re-engagement from dormant users, key levers Robinhood needs to maintain its blistering growth heading into Q3.

LikeFolio data continues to show tremendous user engagement.

Hims (HIMS): Major Partnership Update

Hims sold off hard after Novo Nordisk terminated its Wegovy distribution agreement, accusing the company of deceptive marketing and unauthorized compounding of semaglutide. CEO Andrew Dudum fired back, calling the move anticompetitive and reaffirming Hims’ commitment to weight-loss access through both branded and compounded options. The stock bounced sharply Thursday and continued to push higher today as investors responded to Dudum’s public stance. 

Long term, the confrontation cements Hims’ role as a defender of consumer access in an increasingly competitive obesity drug market.

Our bullish HIMS outlook remains unchanged. We are further impressed by the team the company is building and will continue to monitor consumer demand for any major shifts.

Advanced Micro Devices (AMD): +12%

Nice move higher from our newest position! AMD gained ground this week after Melius Research upgraded the stock to Buy and raised its price target to $175, citing upside from AI accelerators and custom silicon. The move also came as Nvidia extended its rally, pushing the entire chip sector higher on renewed conviction in enterprise AI demand. Investors are positioning around AMD as the next beneficiary of AI infrastructure buildouts, especially with data center traction expected to accelerate through the second half.

Magnite (MGNI): +12%

No major news from Magnite this week. Investor confidence continues to rise despite reports of insider selling. We’re monitoring the streaming sector and company-specific demand very closely. 

Viant Technology (DSP): +6% – Closing our position

No Viant-specific announcements occurred last, but recent industry headlines have sparked fresh investor scrutiny. Bloomberg reported on June 18 that HHS Secretary RFK Jr. and the Trump administration are weighing policies to curb DTC pharma ads by eliminating tax deductions or enforcing stricter side-effect disclosures That conversation escalated last week after RFK Jr. publicly called for limiting pharma ads on TV, highlighting regulatory risk for ad platforms .

Viant’s DSP provides healthcare and pharma clients access to premium TV and CTV inventory, meaning further ad restrictions could hit a core revenue channel. Sector sentiment has shifted: analysts noted that “drug ads, which are a crucial revenue stream for broadcasters, could be crippled” if RFK Jr.'s proposals move forward. Given DSP’s smaller scale compared to competitors like TTD, even modest budget reallocations would disproportionately impact its growth trajectory.

We’re capitalizing on this week’s move higher to mitigate any losses – and clearing space in our portfolio for our next batch of winners.